Samsung JV seeks second biosimilar approval in Europe

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 16 Mar, 2015

Singapore: Samsung Bioepis, a joint venture between Samsung Biologics and Biogen Idec, has submitted marketing authorization application (MAA) for SB2, its Remicade (Infliximab) biosimilar ...Read more

Merck, China firm to co-develop DNA repair drug

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 14 Nov, 2013

‎Singapore: Merck Serono, the biopharmaceutical division of Merck, has signed a global licensing, co-development, and commercialization agreement with BeiGene, a biotech R&D compa...Read more

Austrinova opens new facility in Singapore

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2015

Singapore: Singapore based biotech firm, Austrianova, has opened a new facility in Singapore to perform research and development and translational research activities for its cell encapsula...Read more

China Biologic subisdiary gets GMP tag

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Dec, 2014

Singapore: Plasma-based biopharmaceutical company, China Biologic Products' subsidiary firm, Shandong Taibang Biological Products has received Good Manufacturing Practices certification fro...Read more

NUS team pioneers a novel technique to deliver biologicals

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 09 Sep, 2014

Singapore: Researchers at the National University of Singapore have invented a novel technique to administer pain-killers and collagen into the body through a minimally invasive procedure. ...Read more

Hope for COPD: Network Verification Challenge

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2014

Singapore: The Network Verification Challenge has generated a comprehensive set of biological models relevant to chronic obstructive pulmonary disease (COPD) which are now available for re...Read more

Amgen unveils new plant in Asia

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Nov, 2014

Singapore: US-based Amgen enters the Asian market with its new 'next-generation' biomanufacturing facility in Singapore. The plant is located in Tuas Biomedical Park. It will maufacture a m...Read more

A*STAR, Japanese bank ink partnership

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Aug, 2014

Singapore: Singapore's Agency for Science, Technology and Research (A*STAR) and Japan's Sumitomo Mitsui Banking Corporation (SMBC) have inked a memorandum of understanding (MOU) to support ...Read more

AmpliPhi, SPH to combat antibiotic-resistant super bugs

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 11 Sep, 2012

Singapore: Australia-based AmpliPhi Biosciences is looking to acquire Brookvale, a Sydney-based Special Phage Services (SPS). The combination of the two companies would result in the creati...Read more

FUJIFILM expands cell manufacturing capacity

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 20 Aug, 2014

Singapore: Gobal contract manufacturing firm, FUJIFILM Diosynth Biotechnologies, has expanded its cell culture manufacturing capabilities with the addition of two 2000L single-use bioreacto...Read more

Biocon starts academy to train biotech professionals

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 12 Nov, 2013

Bangalore: In a first for Asia's bioscience industry, India's leading biotech company, Biocon has started an academy to train biotech professional for the Indian and global industry in asso...Read more

Molecular painting sparks biologics research

Biologics |  Influencers | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2012

At the University of Veterinary Medicine in Vienna, Austria, Dr John Dangerfield and Dr Brian Salmons along with Dr Christoph Metzner developed a technology for quick and easy modification ...Read more

Making kidney dialysis cheaper and quicker

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2016

Singapore: Scientists at the Indian Institute of Technology- Bombay, India have developed a unique membrane that can effectively reduce dialysis time and cut costs to almost 50 percent. The...Read more

Hospira recalls plum infusion pump for over blood delivery risk

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 19 Mar, 2014

Singapore: FDA has stated that biologic drug company, Hospira, has identified an incorrect set component supplied and used during the manufacturing process of Hemostat Dual Channel Plum Set...Read more

Pharmaxis, Synairgen to develop drugs for fatal lung disease

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2015

Singapore: Australian pharmaceutical company Pharmaxis, and UK biotechnology company, Synairgen, have entered into a research collaboration to develop a selective inhibitor to the lysyl oxi...Read more

BioTime appoints Adi Mohanty as COO

Biologics |  Influencers | By BioSpectrum Bureau  | 0 Comment | 30 Dec, 2014

Singapore: Stem cell therapy company, BioTime, has appointed Mr Adi Mohanty, ex-Shire executive, as chief operating officer and would be reponsible to build BioTime's business through the d...Read more

Baxter inaugurates biologics facility in Singapore

Biologics |  News | By BioSpectrum Bureau  | 0 Comment | 07 Aug, 2014

Singapore: Baxter International has launched an advanced recombinant biologic facility in Singapore. The suite supports the processing of ADVATE [Antihemophilic Factor (Recombinant)], full...Read more

Baxter recalls dialysis solution

Biologics |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 15 Aug, 2014

Singapore: Baxter is voluntarily initiating a recall of two lots of DIANEAL Low Calcium Peritoneal Dialysis Solution with 2.5 percent Dextrose 5000mL (Ambu-Flex II) to the hospital/user lev...Read more